Study on the synthesis technology of anticancer drug Gilteritinib fumarate
Crossref DOI link: https://doi.org/10.1007/s11172-023-3977-9
Published Online: 2023-09-05
Published Print: 2023-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Huashen
Chen, Lu
Chen, Yuanguang
Fu, Yang
Xu, Feng
Chen, Guoliang
Text and Data Mining valid from 2023-08-01
Version of Record valid from 2023-08-01
Article History
Received: 21 October 2022
Revised: 30 December 2022
Accepted: 9 January 2023
First Online: 5 September 2023
Ethics
: The authors declare no competing interests.